Answers are grounded in this paper and cite their sources.
In this review, human methotrexate dosing regimens, as well as their relationship to data from in vitro cell culture and in vivo animal and human studies, are discussed. Low-dose, intermediate-dose, and high-dose therapies are covered. Since in vitro and in vivo screenings of potential cancer drugs are commonplace in the development of cancer chemotherapy, comparisons of the three criteria for effectiveness are important.
No takes yet. Share an insight, caveat, or question.
Rizvi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: